TNM CLASSIFICATION IN LUNG CANCER 8TH VERSION – DIAGNOSTIC IMAGING TO NOTE

Cung Văn Công1,
1 National Lung Hospital

Main Article Content

Abstract

The TNM cancer classification system (T: stands for Tumor, meaning U; N: stands for Node, means lymph nodes; and M: stands for Metastasis, meaning metastasis) is UIAC (Union International Against Cancer) was first introduced in 1944 of the last century, and was officially published as a paper book in 1968. This classification system since its inception includes 5 goals, so far still unchanged: (1) Assistance in treatment planning; (2) Prognosis of disease condition; (3) Evaluation of treatment results; (4) Make it easier to exchange and compare information between treatment facilities (due to the common use of a unified system); (5) As a basis to contribute to the study of malignancies. Since 1987, UIAC has cooperated with AJCC (American Joint Committee on Cancer) to continue to research and improve the TNM classification system, turning it into a world standard classification system in cancer, including lung cancer. The official TNM versions that have been announced include: 5; 6; 7; 8. Version 8 was announced in 2017 and has been in use ever since. This article will specifically interpret imaging situations in order to unify their use in clinical practice.

Article Details

References

1. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010 Jun;17(6):1471-4. doi: 10.1245/s10434-010-0985- 4. PMID:20180029
2. Feng SH, Yang ST. The new 8th TNM staging system of lung cancer and its potential imaging interpretation pitfalls and limitations with CT image demonstrations. Diagn Interv Radiol. 2019 Jul;25(4):270-279. doi: 10.5152/dir.2019.18458.PMID: 31295144
3. Lim W, Ridge CA, Nicholson AG, Mirsadraee S. The 8th lung cancer TNM classification and clinical staging system: review of the changes and clinical implications. Quant Imaging Med Surg. 2018 Aug; 8(7):709-718. doi: 10.21037/qims.2018.08.02.PMID: 30211037
4. Taber S, Pfannschmidt J. Validation of the 8th lung cancer TNM classification and clinical staging system in a German cohort of surgically resected patients. Innov Surg Sci. 2020 Aug 12; 5(1-2):1-9. doi: 10.1515/iss-2020-0010. eCollection 2020 Mar.PMID: 33506088
5. Kutob L, Schneider F. Lung Cancer Staging. Surg Pathol Clin. 2020 Mar;13(1):57-71. doi: 10.1016/j.path.2019.10.003. Epub 2019 Dec 18.PMID: 32005435
6. Wankhede D. Evaluation of Eighth AJCC TNM Sage for Lung Cancer NSCLC: A Meta-analysis. Ann Surg Oncol. 2021 Jan;28(1):142-147. doi: 10.1245/s10434-020-09151-9. Epub 2020 Sep 20.PMID: 32951092
7. Li S, Yan S, Lu F, et al. Validation of the 8th Edition Nodal Staging and Proposal of New Nodal Categories for Future Editions of the TNM Classification of Non-Small Cell Lung Cancer. Ann Surg Oncol. 2021 Aug; 28(8):4510-4516. doi: 10.1245/s10434-020-09461-y. Epub 2021 Jan 2.PMID: 33389296
8. Hattori A, Suzuki K, Takamochi K, et al. Japan Clinical Oncology Group Lung Cancer Surgical Study Group.Prognostic impact of a ground-glass opacity component in clinical stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2021 Apr;161(4):1469-1480. doi: 10.1016/j.jtcvs.2020.01.107. Epub 2020 Apr 6.PMID: 32451073
9. Matilla JM, Zabaleta M, Martínez-Téllez et al. New TNM staging in lung cancer (8th edition) and future perspectives. J Clin Transl Res. 2020 Sep 2;6(4):145-154. eCollection 2020 Oct 29.PMID: 33521375